ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » South Dakota » Ophthalmology

Top Ophthalmology Prescribers in South Dakota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CURT WISCHMEIER M.D.

Ophthalmology

6,028

$406K

960
918 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

70%
prescriptions for brand name drugs

Avg: 60%

$67
Average prescription price

Avg: $57

GREGORY OSMUNDSON M.D.

Ophthalmology

5,976

$267K

817
762 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

51%
prescriptions for brand name drugs

Avg: 60%

$45
Average prescription price

Avg: $57

PATRICK KING M.D.

Ophthalmology

2,953

$164K

495
481 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

63%
prescriptions for brand name drugs

Avg: 60%

$55
Average prescription price

Avg: $57

JOHN BORMES M.D.

Ophthalmology

2,844

$140K

573
534 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

68%
prescriptions for brand name drugs

Avg: 60%

$49
Average prescription price

Avg: $57

MONTE DIRKS M.D.

Ophthalmology

2,693

$166K

545
488 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

54%
prescriptions for brand name drugs

Avg: 60%

$62
Average prescription price

Avg: $57

BETH BRUENING M.D.

Ophthalmology

2,590

$180K

404
372 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

73%
prescriptions for brand name drugs

Avg: 60%

$69
Average prescription price

Avg: $57

PAUL WRIGHT MD

Ophthalmology

2,548

$119K

596
560 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

65%
prescriptions for brand name drugs

Avg: 60%

$47
Average prescription price

Avg: $57

JOHN BERDAHL M.D.

Ophthalmology

2,464

$194K

467
443 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

84%
prescriptions for brand name drugs

Avg: 60%

$79
Average prescription price

Avg: $57

DUSTIN DIERKS MD

Ophthalmology

2,366

$88K

496
467 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

16%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

47%
prescriptions for brand name drugs

Avg: 60%

$37
Average prescription price

Avg: $57

MICHAEL EIDE M.D.

Ophthalmology

2,323

$80K

503
470 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

50%
prescriptions for brand name drugs

Avg: 60%

$34
Average prescription price

Avg: $57

RAY BIRKENKAMP M.D.

Ophthalmology

2,163

$136K

342
327 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

60%
prescriptions for brand name drugs

Avg: 60%

$63
Average prescription price

Avg: $57

ROBERT NIXON M.D.

Ophthalmology

2,050

$146K

275
249 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

63%
prescriptions for brand name drugs

Avg: 60%

$71
Average prescription price

Avg: $57

DAVID WEST M.D.

Ophthalmology

1,836

$77K

340
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

17%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

47%
prescriptions for brand name drugs

Avg: 60%

$42
Average prescription price

Avg: $57

STEPHEN KHACHIKIAN M.D.

Ophthalmology

1,726

$82K

374
338 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

62%
prescriptions for brand name drugs

Avg: 60%

$47
Average prescription price

Avg: $57

MICHAEL MORAN MD

Ophthalmology

1,610

$78.3K

295
282 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

50%
prescriptions for brand name drugs

Avg: 60%

$49
Average prescription price

Avg: $57

WAYNE SNYDER M.D.

Ophthalmology

1,532

$132K

283
271 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

86%
prescriptions for brand name drugs

Avg: 60%

$86
Average prescription price

Avg: $57

GAIL BERNARD

Ophthalmology

1,510

$85.6K

321
297 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

57%
prescriptions for brand name drugs

Avg: 60%

$57
Average prescription price

Avg: $57

JOHN SLINGSBY M.D.

Ophthalmology

1,421

$80.7K

387
367 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

64%
prescriptions for brand name drugs

Avg: 60%

$57
Average prescription price

Avg: $57

PAULA HICKS M.D.

Ophthalmology

1,411

$76.9K

382
372 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

20%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

42%
prescriptions for brand name drugs

Avg: 60%

$55
Average prescription price

Avg: $57

MICHAEL VANDEN BOSCH MD

Ophthalmology

1,409

$95.4K

352
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

56%
prescriptions for brand name drugs

Avg: 60%

$68
Average prescription price

Avg: $57

ALISON TENDLER M.D.

Ophthalmology

1,197

$93.9K

309
285 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

77%
prescriptions for brand name drugs

Avg: 60%

$78
Average prescription price

Avg: $57

JOHN HERLIHY

Ophthalmology

1,145

$65.8K

334
317 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

49%
prescriptions for brand name drugs

Avg: 60%

$57
Average prescription price

Avg: $57

KAREN DICKES D.O.

Ophthalmology

1,115

$88.6K

293
279 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

78%
prescriptions for brand name drugs

Avg: 60%

$79
Average prescription price

Avg: $57

BRYAN HAMMER M.D.

Ophthalmology

1,080

$44.7K

463
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

56%
prescriptions for brand name drugs

Avg: 60%

$41
Average prescription price

Avg: $57

THOMAS WHITE M.D.

Ophthalmology

1,008

$56.2K

158
134 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

51%
prescriptions for brand name drugs

Avg: 60%

$56
Average prescription price

Avg: $57

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank